Ipamorelin
Overview[edit]
Ipamorelin is a synthetic peptide that functions as a growth hormone secretagogue. It is part of a class of compounds known as growth hormone releasing peptides (GHRPs), which stimulate the release of growth hormone (GH) from the anterior pituitary gland. Ipamorelin is known for its selectivity and potency, making it a subject of interest in both clinical and research settings.
Mechanism of Action[edit]
Ipamorelin works by mimicking the action of the natural hormone ghrelin, which binds to the growth hormone secretagogue receptor (GHSR) in the brain. This binding stimulates the pituitary gland to release growth hormone. Unlike some other GHRPs, Ipamorelin does not significantly affect the levels of other hormones such as cortisol or prolactin, which contributes to its favorable side effect profile.
Clinical Applications[edit]
Ipamorelin is primarily used in research settings to study its effects on growth hormone release and its potential therapeutic applications. It has been investigated for its potential to:
- Promote muscle growth and fat loss
- Improve bone density
- Enhance recovery from injuries
- Support anti-aging therapies
Pharmacokinetics[edit]
Ipamorelin is typically administered via subcutaneous injection. It has a rapid onset of action, with growth hormone levels peaking within 15 to 30 minutes after administration. The half-life of Ipamorelin is approximately 2 hours, which allows for multiple daily dosing if necessary.
Safety and Side Effects[edit]
Ipamorelin is generally well-tolerated, with a low incidence of side effects. Commonly reported side effects include:
Due to its selective action, Ipamorelin does not significantly increase levels of cortisol or prolactin, reducing the risk of side effects associated with these hormones.
Research and Development[edit]
Research on Ipamorelin continues to explore its potential benefits and applications. Studies are ongoing to determine its efficacy in various clinical scenarios, including its role in muscle wasting conditions and age-related decline in growth hormone levels.
Related Pages[edit]
Gallery[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
